Proteomic Profiling of Urine From Hospitalized Patients With Severe Pneumonia due to SARS-CoV-2 vs Other Causes: A Preliminary Report.

Lindsay Wilson, Ju-Wei Chang, Stuart Meier, Tariq Ganief, Naadir Ganief, Suzette Oelofse, Vicky Baillie, Marta C Nunes, Shabir A Madhi, Jonathan Blackburn, Keertan Dheda
Author Information
  1. Lindsay Wilson: Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
  2. Ju-Wei Chang: Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
  3. Stuart Meier: Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
  4. Tariq Ganief: Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  5. Naadir Ganief: Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  6. Suzette Oelofse: Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
  7. Vicky Baillie: South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  8. Marta C Nunes: South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. ORCID
  9. Shabir A Madhi: South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  10. Jonathan Blackburn: Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  11. Keertan Dheda: Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.

Abstract

The pathogenesis of coronavirus disease 2019 (COVID-19) pneumonia remains poorly understood. The urine proteome of hospitalized patients with severe COVID-19 pneumonia, compared with severe non-COVID-19 pneumonia controls, was distinct and associated with lower abundance of several host proteins. Protein-specific machine learning analysis outlined biomarker combinations able to differentiate COVID-19 pneumonia from non-COVID-19 pneumonia controls.

Keywords

References

  1. Genomics. 2001 Mar 15;72(3):243-51 [PMID: 11401439]
  2. PLoS One. 2020 Aug 31;15(8):e0238479 [PMID: 32866217]
  3. Lancet Digit Health. 2022 Oct;4(10):e727-e737 [PMID: 36057526]
  4. Partial Differ Equ Appl Math. 2022 Jun;5:100212 [PMID: 38621002]
  5. Emerg Microbes Infect. 2021 Dec;10(1):123-131 [PMID: 33393450]
  6. Mol Cancer Res. 2020 Jul;18(7):943-954 [PMID: 32205365]
  7. Urol J. 2020 Sep 05;17(5):433-441 [PMID: 32888186]
  8. Appl Immunohistochem Mol Morphol. 2021 Sep 1;29(8):570-575 [PMID: 33938481]
  9. Proteomics. 2020 Sep 10;:e2000202 [PMID: 32960510]
  10. Cell Rep. 2022 Jan 18;38(3):110271 [PMID: 35026155]
  11. Clin Cancer Res. 2021 Mar 1;27(5):1452-1462 [PMID: 33262134]
  12. Urine (Amst). 2020;2:1-8 [PMID: 33688631]
  13. F1000Res. 2021 Jul 8;10:550 [PMID: 35106136]
  14. Kidney Int Rep. 2021 Dec;6(12):3064-3069 [PMID: 34642644]
  15. J Proteome Res. 2021 Jul 2;20(7):3404-3413 [PMID: 34077217]
  16. Signal Transduct Target Ther. 2021 Apr 15;6(1):155 [PMID: 33859163]
  17. J Infect Public Health. 2022 Jul;15(7):726-733 [PMID: 35687982]
  18. Sci Rep. 2020 May 21;10(1):8390 [PMID: 32439918]
  19. Nat Rev Immunol. 2022 Jan;22(1):47-56 [PMID: 34837062]
  20. Blood. 2019 Feb 7;133(6):511-520 [PMID: 30523120]
  21. Sci China Life Sci. 2022 Sep;65(9):1866-1880 [PMID: 35290573]
  22. Lancet Infect Dis. 2020 Aug;20(8):e192-e197 [PMID: 32539990]
  23. BMC Biol. 2011 Aug 11;9:54 [PMID: 21834987]
  24. EClinicalMedicine. 2021 Jun;36:100883 [PMID: 33969282]
  25. Nat Commun. 2020 Nov 17;11(1):5859 [PMID: 33203833]
  26. Int J Mol Sci. 2021 May 06;22(9): [PMID: 34066339]
  27. Nat Commun. 2022 Apr 5;13(1):1812 [PMID: 35383197]
  28. Expert Rev Vaccines. 2022 Jul;21(7):957-974 [PMID: 33749491]
  29. Lancet Infect Dis. 2022 Jul;22(7):967-976 [PMID: 35468331]

Word Cloud

Created with Highcharts 10.0.0pneumoniaCOVID-19pathogenesishospitalizedseverenon-COVID-19controlscoronavirusdisease2019remainspoorlyunderstoodurineproteomepatientscompareddistinctassociatedlowerabundanceseveralhostproteinsProtein-specificmachinelearninganalysisoutlinedbiomarkercombinationsabledifferentiateProteomicProfilingUrineHospitalizedPatientsSeverePneumoniadueSARS-CoV-2vsCauses:PreliminaryReport

Similar Articles

Cited By